Teva Pharmaceutical Industries Limited (TEVJF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 10:08AM EDT
| Previous Close | 11.75 |
| Open | 11.75 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 11.75 - 11.75 |
| 52 Week Range | 7.03 - 15.87 |
| Volume | |
| Avg. Volume | 1,877 |
| Market Cap | 15.598B |
| Beta (5Y Monthly) | 1.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.50 |
| Earnings Date | May 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Nov 28, 2017 |
| 1y Target Est | N/A |
Investor's Business DailyA Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
As the earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation are due to report.
ZacksUnlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Business WireTeva to Present at the 2024 Bank of America Healthcare Conference
TEL AVIV, Israel, May 02, 2024--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the 2024 Bank of America Healthcare Conference on Tuesday, May 14, 2024. The presentation will begin at 8:40 A.M. Pacific Time (11:40 A.M. Eastern Time).
© 2024 Yahoo. All rights reserved.